S&P 500 7,498.96 -0.14% NASDAQ 25,690.90 -0.57% DOW 52,218.58 -0.01% R2K 2,959.94 -0.92% VIX 16.64 -2.40% US 10Y 4.66 +0.63% DXY 101.11 -0.07% GOLD 4,140.60 +1.71% CRUDE 86.42 +1.78% BITCOIN 65,906.58 -0.90%
Next Bullish Trade
Sign in
ARDX

Ardelyx, Inc. NGM · ARDX

$5.08 -0.01 (-0.20%)
Pullback · -1.08σ
+ Compare Open in Sniper

Valuation

Market cap $1.3B
P/E (ttm) —
Forward P/E 9.9
Beta (5y) 0.60
Shares out 247.0M
Div yield —

Profitability & returns

ROE -39.5%
Net margin -13.6%
FCF margin 0.0%
Debt / equity 1.58

Trading information

Last price $5.08
Day range $5.00 – $5.09
52-wk range $4.93 – $8.40
Avg volume 4.0M
RSI (2) 22.1
Trend zone Pullback
52-week range · today's price
$4.93$8.40

Company

Sector Healthcare
Industry Biotechnology
Exchange NGM
Next earnings 2026-04-30

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, I…